135 related articles for article (PubMed ID: 34732437)
1. The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric Cancer.
Okubo K; Arigami T; Matsushita D; Uenosono Y; Yanagita S; Kijima T; Tsuruda Y; Noda M; Sasaki K; Mori S; Kurahara H; Ohtsuka T
Anticancer Res; 2021 Nov; 41(11):5643-5649. PubMed ID: 34732437
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
3. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy.
Lu J; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX
Surg Oncol; 2013 Sep; 22(3):167-71. PubMed ID: 23787074
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
5. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
6. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer.
Kambara Y; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Yuasa N
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1918-1924. PubMed ID: 32814681
[TBL] [Abstract][Full Text] [Related]
7. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Predictors After Surgical Intervention for Stage IV Gastric Cancer.
Suzuki S; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Oshikiri T; Kakeji Y
Anticancer Res; 2022 Mar; 42(3):1541-1546. PubMed ID: 35220250
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy.
Bilici A; Selcukbiricik F; Seker M; Oven BB; Olmez OF; Yildiz O; Olmuscelik O; Hamdard J; Acikgoz O; Cakir A; Kapran Y; Balik E; Oncel M
Oncol Res Treat; 2019; 42(4):209-216. PubMed ID: 30870846
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumor deposits in gastric cancer patients who underwent radical surgery.
Sun Z; Wang ZN; Xu YY; Zhu GL; Huang BJ; Xu Y; Liu FN; Zhu Z; Xu HM
Surgery; 2012 Jun; 151(6):871-81. PubMed ID: 22386276
[TBL] [Abstract][Full Text] [Related]
13. Tumor Size Improves the Accuracy of the Prognostic Prediction of Lymph Node-Negative Gastric Cancer.
Liang Y; Liu L; Xie X; Xia L; Meng J; Xu R; He D
J Surg Res; 2019 Aug; 240():89-96. PubMed ID: 30913463
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic factors and surgical indications for metastatic gastric cancer.
Mohri Y; Tanaka K; Ohi M; Saigusa S; Yasuda H; Toiyama Y; Araki T; Inoue Y; Kusunoki M
BMC Cancer; 2014 Jun; 14():409. PubMed ID: 24906485
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer.
Gong X; Zhang H
J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318
[TBL] [Abstract][Full Text] [Related]
19. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
[TBL] [Abstract][Full Text] [Related]
20. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
